Ascend Pain & Wellness introduces a groundbreaking uterine fibroid treatment option that transforms the standard care for this condition. The newly unveiled uterine fibroid embolization (UFE) technique, available at their facilities nationwide, offers a minimally invasive alternative to traditional surgical options such as hysterectomy and myomectomy. This method significantly reduces recovery times and lowers surgical risks, representing a major step forward in improving treatment accessibility and outcomes for patients.
Uterine fibroids affect an estimated 70%–80% of women before the age of 50, often necessitating invasive procedures with extensive recovery periods. The UFE procedure begins with the insertion of a catheter into an artery, followed by the precise embolization of the blood vessels that supply fibroids, minimizing the typical symptoms without the need for surgical intervention.
“This technique targets fibroids directly, alleviating symptoms effectively while allowing patients to return home the same day,” stated the spokesperson at Ascend Pain & Wellness.
Ascend Pain & Wellness is dedicated to providing cutting-edge healthcare solutions. The introduction of the uterine artery embolization treatment underscores this commitment, offering highly effective options that cater to patient needs. This particular approach emphasizes non-surgical treatment for uterine fibroids, focusing on less invasive medical interventions that prioritize patient comfort and recovery.
“Uterine artery embolization represents a pivotal shift in fibroid management, focusing on precision and patient-centered care,” said the clinic spokesperson.
He emphasized the outpatient nature of UFE and the high rate of patient improvement post-treatment, stating, “Patients experience significant symptom relief faster than traditional methods, with most returning to normal activities within a week—a fraction of the time required after surgery.”
For those seeking uterine fibroid embolization near me, Ascend Pain & Wellness offers this treatment at numerous locations nationwide, ensuring that care is accessible for all.
While UFE is generally safe like all medical procedures, it involves certain risks, such as infection, bleeding, or adverse reactions to the embolization material. These risks are relatively rare and are comprehensively managed with pre-procedure screenings and post-procedure care at all Ascend Pain & Wellness facilities.
The broader adoption of UFE by Ascend Pain & Wellness signifies a crucial step toward more sustainable healthcare practices. By reducing the need for extensive surgical interventions, UFE not only lessens the immediate physical impact on patients but also contributes to the long-term sustainability of healthcare resources.
Additionally, the shorter hospital stays and decreased need for post-operative care translate to lower medical bills, making this an economically advantageous option for both healthcare facilities and patients.
For more details about Ascend Pain & Wellness’s uterine fibroid treatment without surgery, visit https://www.ascendpainandwellness.com/.
About Ascend Pain & Wellness
Ascend Pain & Wellness is a leading healthcare provider dedicated to advancing medical treatments and improving patient outcomes. With a network of top-notch clinics across the nation, Ascend specializes in minimally invasive procedures that offer significant health benefits and reduced recovery times. Its mission is to empower patients by providing innovative, effective treatments that enhance their quality of life. Each Ascend facility is staffed by renowned medical professionals, committed to providing personal care to their patients. Ascend Pain & Wellness believes in transforming lives through better healthcare solutions, tailored to meet the unique needs of patients.
###
Media Contact
Dr. Omar Said
Address: 947 S. Mannheim Road, Westchester, IL 60154
Phone: (708) 550-7005
Website: https://www.ascendpainandwellness.com/
Email: info@ascendpainandwellness.com
newsroom: news.38digitalmarket.com
Source: 38 Digital Market News
Release ID: 1036660
